Oxidative stress, innate immunity, and age-related macular degeneration

Oxidative stress, innate immunity, and age-related macular degeneration

Age-related macular degeneration (AMD) is a leading cause of vision loss affecting tens of millions of elderly worldwide. Early AMD is characterized by the appearance of soft drusen, as well as pigmentary changes in the retinal pigment epithelium (RPE). These soft, confluent drusen can progress into...

Full description

Bibliographic Details
Main Authors:	Wei Fan, Hongjun Du, Xu Xiao, Peter X. Shaw, Travis Stiles, Christopher Douglas, Daisy Ho
Format:	Article
Language:	English
Published:	AIMS Press 2016-05-01
Series:	AIMS Molecular Science
Subjects:	age-related macular degeneration oxidative stress innate immunity complement factor H inflammation
Online Access:	http://www.aimspress.com/Molecular/article/770/fulltext.html

Similar Items

Pathogenic microRNAs (miRNAs) common to brain and retinal degeneration; recent observations in Alzheimer’s disease (AD) and age-related macular degeneration (AMD)
by: James M Hill, et al.
Published: (2015-11-01)

Innate immune biology in age-related macular degeneration
by: Karina Ascunce, et al.
Published: (2023-02-01)

Advances in complement factor H gene in age-related macular degeneration
by: Jin-Tao Xia, et al.
Published: (2015-01-01)

Association of age-related macular degeneration with complement activation products, smoking, and single nucleotide polymorphisms in South Carolinians of European and African descent
by: Bärbel Rohrer, et al.
Published: (2019-02-01)

Genetic Risk in Families with Age-Related Macular Degeneration
by: Anita de Breuk, MD, et al.
Published: (2021-12-01)

Inflammasome Activation in Retinal Pigment Epithelium from Human Donors with Age-Related Macular Degeneration
by: Mara C. Ebeling, et al.
Published: (2022-06-01)

C-Reactive Protein As a Mediator of Complement Activation and Inflammatory Signaling in Age-Related Macular Degeneration
by: Kathleen R. Chirco, et al.
Published: (2018-03-01)

Mechanism of oxidative stress and complement in the pathogenesis of age-related macular degeneration
by: Yan-Fang Xiang, et al.
Published: (2013-08-01)

Advances in study of complement activation and autophagy on age-related macular degeneration
by: Yu-Lu Liu, et al.
Published: (2020-06-01)

Interlink between Inflammation and Oxidative Stress in Age-Related Macular Degeneration: Role of Complement Factor H
by: Sara Romero-Vazquez, et al.
Published: (2021-06-01)

C-reactive protein-complement factor H axis as a biomarker of activity in early and intermediate age-related macular degeneration
by: Lena Giralt, et al.
Published: (2024-04-01)

The Long Pentraxin PTX3 as a New Biomarker and Pharmacological Target in Age-Related Macular Degeneration and Diabetic Retinopathy
by: Matteo Stravalaci, et al.
Published: (2022-01-01)

Associations between the Complement System and Choroidal Neovascularization in Wet Age-Related Macular Degeneration
by: Emilie Grarup Jensen, et al.
Published: (2020-12-01)

Complement System and Potential Therapeutics in Age-Related Macular Degeneration
by: Young Gun Park, et al.
Published: (2021-06-01)

Relationships between Lipid-Related Metabolites and Age-Related Macular Degeneration Vary with Complement Genotype
by: Ralene Zi Hui Sim, MD, et al.
Published: (2022-12-01)

Systemic Complement Activation Profiles in Nonexudative Age-Related Macular Degeneration
by: Jonathan B. Lin, MD, PhD, et al.
Published: (2022-06-01)

Association of Serum Complement C1q and C3 Level with Age-Related Macular Degeneration in Women
by: Ma Y, et al.
Published: (2022-01-01)

A Review of the Role of the Intestinal Microbiota in Age-Related Macular Degeneration
by: Phoebe Lin, et al.
Published: (2021-05-01)

Systemic Complement Activation Profiles in Nonexudative Age-Related Macular Degeneration: A Meta-Analysis
by: Jonathan B. Lin, et al.
Published: (2022-04-01)

Role of Complement in the Onset of Age-Related Macular Degeneration
by: Niloofar Piri, et al.
Published: (2023-05-01)

Preliminary in vitro and in vivo assessment of a new targeted inhibitor for choroidal neovascularization in age-related macular degeneration
by: Li W, et al.
Published: (2016-10-01)

Complement Factor H Y402H and LOC387715 A69S Polymorphisms in Association with Age-Related Macular Degeneration in Iran
by: Hossein Nazari Khanamiri, et al.
Published: (2014-01-01)

Analysis of the association between CFH Y402H polymorphism and response to intravitreal ranibizumab in patients with neovascular age-related macular degeneration (nAMD)
by: Nur Afiqah Mohamad, et al.
Published: (2018-08-01)

Complement factor H and LOC387715/ARMS2/HTRA1 variant's frequencies and phenotypic associations in neovascular age-related macular degeneration, a pilot study
by: Reza Karkhane, et al.
Published: (2016-03-01)

Terminal Complement Activation Is Induced by Factors Released from Endplate Tissue of Disc Degeneration Patients and Stimulates Expression of Catabolic Enzymes in Annulus Fibrosus Cells
by: Amelie Kuhn, et al.
Published: (2023-03-01)

Targeting the Complement Cascade for Treatment of Dry Age-Related Macular Degeneration
by: Prem N. Patel, et al.
Published: (2022-08-01)

The role of inflammation in age-related macular degeneration
by: Diana Florina Tricorache, et al.
Published: (2023-10-01)

Identification of Diagnostic Biomarkers and Their Correlation with Immune Infiltration in Age-Related Macular Degeneration
by: Yuyang Zeng, et al.
Published: (2021-06-01)

Dynamic Interplay of Innate and Adaptive Immunity During Sterile Retinal Inflammation: Insights From the Transcriptome
by: Riccardo Natoli, et al.
Published: (2018-07-01)

Impaired Mitochondrial Function in iPSC-Retinal Pigment Epithelium with the Complement Factor H Polymorphism for Age-Related Macular Degeneration
by: Mara C. Ebeling, et al.
Published: (2021-04-01)

Potential Role of Myeloid-Derived Suppressor Cells (MDSCs) in Age-Related Macular Degeneration (AMD)
by: Anu Kauppinen, et al.
Published: (2020-03-01)

Neuroprotection for Age-Related Macular Degeneration
by: Jonathan B. Lin, MD, PhD, et al.
Published: (2022-12-01)

Clinical validation of a genetic model to estimate the risk of developing choroidal neovascular age-related macular degeneration
by: Hageman Gregory S, et al.
Published: (2011-07-01)

Quantitative proteomic analysis of aqueous humor from patients with drusen and reticular pseudodrusen in age-related macular degeneration
by: Je-Hyun Baek, et al.
Published: (2018-11-01)

A Clinical and Preclinical Assessment of Clinical Trials for Dry Age-Related Macular Degeneration
by: Muhammad Abidi, BS, et al.
Published: (2022-12-01)

Comparison of efficacy between Ranibizumab and Conbercept for wet age-related macular degeneration
by: Qiang Fan, et al.
Published: (2018-08-01)

Benefits of plant carotenoids against age-related macular degeneration
by: Dao Nguyen, et al.
Published: (2023-07-01)

Genetic risk factors and age-related macular degeneration (AMD)
by: Maryam Mousavi, et al.
Published: (2013-10-01)

Brolucizumab in Neovascular Age-Related Macular Degeneration – Indian Real-World Experience: The BRAILLE Study
by: Chakraborty D, et al.
Published: (2021-09-01)

Role of amyloid β in age-related macular degeneration
by: Lu Wang, et al.
Published: (2018-07-01)